Literature DB >> 1383894

HT7, Neurothelin, Basigin, gp42 and OX-47--many names for one developmentally regulated immuno-globulin-like surface glycoprotein on blood-brain barrier endothelium, epithelial tissue barriers and neurons.

H Seulberger1, C M Unger, W Risau.   

Abstract

The antigens HT7 and Neurothelin were recently described as inducible membrane glycoproteins on chick blood-brain barrier endothelium. Our results demonstrate that the Neurothelin antibody 1W5 does recognize the isolated HT7 protein as well as the HT7 protein expressed by COS-1 cells transfected with the HT7 cDNA. Therefore, the HT7 and Neurothelin epitopes can be found on an unique glycoprotein. By low stringency hybridization we have isolated the murine cDNA clone encoding the homologous murine protein. The nucleotide sequence of the open reading frame is identical to that of the cDNA clones encoding the gp42 protein and the Basigin antigen expressed in F9 cells and in the early mouse embryo. The murine amino acid sequence shows 94% identity with the rat OX-47 membrane glycoprotein which was shown to be expressed in blood-brain barrier endothelium and several epithelial cell layers. These results demonstrate that HT7, Neurothelin, gp42, Basigin and OX-47 are different names for probably the same glycoprotein in different species.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383894     DOI: 10.1016/0304-3940(92)90690-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Molecular characterization of U937-dependent T-cell co-stimulation.

Authors:  T J Stonehouse; V E Woodhead; P S Herridge; H Ashrafian; M George; B M Chain; D R Katz
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

2.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.

Authors:  P Kirk; M C Wilson; C Heddle; M H Brown; A N Barclay; A P Halestrap
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

3.  The basolateral targeting signal of CD147 (EMMPRIN) consists of a single leucine and is not recognized by retinal pigment epithelium.

Authors:  Ami A Deora; Diego Gravotta; Geri Kreitzer; Jane Hu; Dean Bok; Enrique Rodriguez-Boulan
Journal:  Mol Biol Cell       Date:  2004-06-23       Impact factor: 4.138

4.  Modulation of MCT3 expression during wound healing of the retinal pigment epithelium.

Authors:  Shannon Gallagher-Colombo; Arvydas Maminishkis; Susan Tate; Gerald B Grunwald; Nancy J Philp
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

Review 5.  Lactate transport in skeletal muscle - role and regulation of the monocarboxylate transporter.

Authors:  C Juel; A P Halestrap
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

Review 6.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

7.  Basigin-2 is a cell surface receptor for soluble basigin ligand.

Authors:  Robert J Belton; Li Chen; Fernando S Mesquita; Romana A Nowak
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

Review 8.  CD147 immunoglobulin superfamily receptor function and role in pathology.

Authors:  Kathryn T Iacono; Amy L Brown; Mark I Greene; Sandra J Saouaf
Journal:  Exp Mol Pathol       Date:  2007-09-07       Impact factor: 3.362

9.  Basigin null mutant male mice are sterile and exhibit impaired interactions between germ cells and Sertoli cells.

Authors:  Jiajia Bi; Yanfen Li; Fengyun Sun; Anja Saalbach; Claudia Klein; David J Miller; Rex Hess; Romana A Nowak
Journal:  Dev Biol       Date:  2013-05-28       Impact factor: 3.582

10.  The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.

Authors:  Jing-yao Dai; Ke-feng Dou; Cong-hua Wang; Pu Zhao; Wayne Bond Lau; Ling Tao; Ya-mei Wu; Juan Tang; Jian-li Jiang; Zhi-nan Chen
Journal:  BMC Cancer       Date:  2009-09-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.